Use of artificial skin constructs in permeation studies of clindamycin phosphate

Pharmazie

Volumn 60, Issue 5, 2005, Pages 350-353

  Hoffmann, C ^a   Muller Goymann C C ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASOCIN; CLINDAMYCIN PHOSPHATE; IBUPROFEN; NITROGEN;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL SKIN; ARTIFICIAL SKIN CONSTRUCT; BIOLOGICAL MODEL; CREAM; DRUG FORMULATION; DRUG PENETRATION; EPIDERMIS CELL; FREEZING; GEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; KERATINOCYTE; NONHUMAN; SKIN FIBROBLAST; SKIN PERMEABILITY; STRATUM CORNEUM;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINDAMYCIN; FIBROBLASTS; FREEZING; HUMANS; IBUPROFEN; KERATINOCYTES; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES; SKIN ABSORPTION; SKIN, ARTIFICIAL;

EID: 18744383073     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Asbill C, Kim N, El-Kattan A, Creek K, Wertz P, Michniak B (2000) Evaluating of a human bio-engineered skin equivalent for drug permeation studies. Pharm Res 17: 1092-1097.
2. Bennett SL, Barry BW, Woodford R (1985) Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control. J Pharm Pharmacol 37: 298-304.
3. Boelsma E, Verhoeven MCH, Ponec M (1999) Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J Invest Dermatol 112: 489-498.
4. Faller C, Bracher M (2002) Reconstructed skin kits: Reproducibility of cutaneous irritancy testing. Skin Pharmacol Appl Skin Physiol 15 (suppl 1): 74-91.
5. Franz TJ (1975) Percutaneous absorption- on the relevance of in vitro data. J Invest Dermatol 64: 190-195.
6. Graeve T, Fuchs H (1999) Dreidimensionale zelluläre Testsysteme. Bioforum 22: 178-180.
7. Hoffmann C, Müller-Goymann CC (2002) Arch. Pharm. Pharm. Med. Chem. 335 (Suppl. 1): 113.
8. Johnson EW, Meunier SF, Roy CJ, Parenteau NL (1992) Serial cultivation of normal human keratinocytes: a defined system for studying the regulation of growth and differentiation. In vitro Cell Dev Biol 28A: 429-435.
9. Merkle ML, Kandsberger M, Noll M, Matthes TH, Fuchs H, Graeve T (1999) Dreidimensionales Hautäquivalent als Testsystem (AST-2000), ALTEX 16: 52.
10. Monteiro-Riviere NA, Inman AO, Snider TH, Blank JA, Hobson DW (1997) Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc Res Tech 37: 172-179.
11. Noll M, Merkle ML, Kandsberger M, Matthes TH, Fuchs H, Graeve T (1999) Reconstructed human skin (AST-2000) as a tool for pharmacotoxicology. ATLA 27: 302.
12. Parentau NL, Nolle CM, Bilbo P, Rosenberg M, Wilkins LM, Johnson EW, Watson S, Mason VS, Bell E (1991) Epidermis generated in vivo: practical considerations and applications. J Cell Biochem 45: 245-251.
13. Poulsen BJ, Young E, Coquilla V, Katz M (1968) Effect of topical vehicle composition on in vitro release of fluocinolone acetonide and its acetate ester. J Control Release 6: 85-97.
14. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 331-344.
15. nd ed., Elsevier, Amsterdam pp. 1387-1403.
16. Ryle CM, Breitkreutz D, Stark HJ, Leigh IM, Steinert PM, Roop D, Fusenig NE (1989) Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in transfected tumorigenic clones. Differentiation 40: 42-54.
17. Schicksnus G, Müller-Goymann CC (2004) Lateral diffusion of ibuprofen in human skin during permeation studies, Skin Pharmacol Physiol 17: 84-90.
18. Schuerer N, Könne A, Schliep V, Barlag K, Goerz G (1993) Lipid composition and synthesis of HaCaT cells, an immortalized human keratinocyte cell line, in comparison with normal human adult keratinocytes. Exp Dermatology 2: 179-185.
19. Specht C, Stoye I, Müller-Goymann CC (1998) Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. Eur J Pharm Biopharm 46: 273-278.
20. Wassermann K, Müller-Goymann CC (2000a) Arch Pharm Med Chem. 333 (Suppl. 1): 34.
21. Wassermann K, Müller-Goymann CC (2000b) Arch Pharm Med Chem. 333 (Suppl. 2): 17.
22. Winkler A, Müller-Goymann CC (2002) Comparative permeation studies for δ-aminolevulinic acid and its n-butyl ester through stratum corneum and artificial skin constructs. Eur J Pharm Biopharm 53: 281-287.
23. Zghoul N, Fuchs R, Lehr CM, Schaefer U (2001) Reconstructed skin equivalents for assessing percutaneous drug absorption from Pharmaceutical formulations. ALTEX 18: 103-106.